NMRA 241220 20.00P (NMRA241220P20000) Stock Options, News & Quotes

US OptionsDetailed Quotes

NMRA241220P20000

Watchlist

0.00
0.000.00%

15min DelayTrading Nov 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Positive Outlook on Neumora Therapeutics Driven by Navacaprant's Potential in MDD Treatment
TipRanksNov 25 02:35 ET
Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)
TipRanksNov 22 06:51 ET · Ratings
Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode
Yahoo FinanceNov 19 08:53 ET
This Biotech's Stock Could Double If Its Treatment for Major Depressive Disorder Succeeds, Says Mizuho
MarketWatchNov 13 11:03 ET
RBC Capital Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $29
Moomoo NewsNov 13 07:31 ET · Ratings
H.C. Wainwright Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $30
Moomoo NewsNov 13 06:31 ET · Ratings

Comments

Kevin Travers

Oct 21 15:18

Columns Nvidia and Apple Pull Nasdaq Higher with Records, Market Falls | Wall Street Today

The market fell Monday, but $NVIDIA (NVDA.US)$ and $Apple (AAPL.US)$ hit all-time highs. Investors will see some heavy hitter earnings this week, including Tesla on Wednesday, where investors will judge the EV firm's Q3 results.
Just after 4 pm, the $S&P 500 Index (.SPX.US)$ fell 18 basis points, the $Dow Inc (DOW.US)$ fell 0.80%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.27% on tech positivity.
MACRO
This...

Will Nvidia dethrone Apple as world's most valuable company?

Kevin Travers

Oct 21 11:09

Columns Monday Market Pulls Back From Highs, With Earnings To Come | Moovin Stonks

Good afternoon traders, happy Monday, October 21st, the start of a brand new week! Investors will see some heavy hitter earnings this week, including the first of the magnificent seven, Tesla reporting on Wednesday. The market is falling Monday, after hitting highs Thursday last week.
My name is Kevin Travers; here are the news stories and animal spirits hitting Wall Street Today.
$Spirit Airlines (SAVE.US)$ jumped more th...

Moomoo AI

Jan 22 06:02

Ms. Pai Panandiker's appointment, with her vast neuropsychiatry commercial expertise, is seen as invaluable for Neumora's potential commercialization of navacaprant and pipeline advancement. Her experience in neuroscience product commercialization is expected to boost Neumora's growth.

Press Release: Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

Moomoo AI

Dec 12, 2023 06:06

CEO of Neumora Therapeutics is optimistic over Mr. Duncan's appointment due to his legal expertise and program strategy, valuable to the company's goal of advancing neuroscience drug development. Duncan highlights Neumora's leading brain disorder pipeline and recent clinical progress.

Press Release: Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

Moomoo AI

Oct 10, 2023 06:54

CEO of Neumora, Henry Gosebruch, values Dr. Lenz's successful trial experience and neuroscience expertise for their pipeline development. Dr. Lenz is excited to contribute significantly to Neumora's R&D and neuropsychiatry programs.

Press Release: Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development